The patient population treated by vascular medicine is becoming older, which goes along with an increasing number of patients presenting with frailty syndrome. The level of frailty determines the outcomes after vascular surgery or interventions. This position paper written by the German Society for Vascular Surgery and...
G. Kolb, Farzin Adili, M. Denkinger et al.· VASA. Zeitschrift fur Gefass...· 0 citations
Background: Endothelial defects in the heart are a contributor to cardiac pathological remodeling and dysfunction, which can be influenced by cardiomyocytes (CMs). Here, we explore cardioprotective crosstalk between CMs and endothelial cells (ECs) under diabetic conditions. Methods: Type 2 diabetes mellitus (T2DM) was...
S. Gare, N. H. Alatawi, Xin-Yi Chen et al.· Circulation Research· 0 citations
Chimeric antigen receptor (CAR) T-cell therapy has substantially improved outcomes in refractory hematologic malignancies but may cause cardiovascular complications, particularly in the context of cytokine release syndrome (CRS). Real-world data on incidence, severity, and prognostic relevance of cancer therapy–related...
J. Voran, C. Richard, Astrid Dempfle et al.· Cardio-Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
